Daniel P. Judge

2003–2025 年に発表

149
論文数
34,668
被引用数
92
h 指数
141
i10 指数

被引用数

Daniel P. Judge の年別被引用数2003 年: 被引用 1 件2004 年: 被引用 9 件2005 年: 被引用 37 件2006 年: 被引用 76 件2007 年: 被引用 139 件2008 年: 被引用 164 件2009 年: 被引用 181 件2010 年: 被引用 196 件2011 年: 被引用 220 件2012 年: 被引用 232 件2013 年: 被引用 284 件2014 年: 被引用 278 件2015 年: 被引用 319 件2016 年: 被引用 271 件2017 年: 被引用 362 件2018 年: 被引用 238 件2019 年: 被引用 1,052 件2020 年: 被引用 1,306 件2021 年: 被引用 1,405 件2022 年: 被引用 1,106 件2023 年: 被引用 818 件2024 年: 被引用 1,285 件2025 年: 被引用 748 件2026 年: 被引用 15 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,995 件、この内訳の 26.2%イギリス: 引用元論文 966 件、この内訳の 8.5%イタリア: 引用元論文 931 件、この内訳の 8.1%ドイツ: 引用元論文 646 件、この内訳の 5.7%オランダ: 引用元論文 639 件、この内訳の 5.6%カナダ: 引用元論文 472 件、この内訳の 4.1%フランス: 引用元論文 450 件、この内訳の 3.9%中国: 引用元論文 439 件、この内訳の 3.8%スペイン: 引用元論文 364 件、この内訳の 3.2%日本: 引用元論文 343 件、この内訳の 3%オーストラリア: 引用元論文 294 件、この内訳の 2.6%ベルギー: 引用元論文 258 件、この内訳の 2.3%
0%26.2%その他 23%

分野

  • Medicine52.6%
  • Biochemistry, Genetics and Molecular Biology43.5%
  • Engineering1.4%
  • Neuroscience0.7%
  • Immunology and Microbiology0.5%
  • Computer Science0.2%
  • その他1.1%

トピック

  • Cardiovascular Effects of Exercise6.4%
  • Cardiomyopathy and Myosin Studies6.3%
  • Amyloidosis: Diagnosis, Treatment, Outcomes5.9%
  • Cardiac electrophysiology and arrhythmias5.2%
  • Connective tissue disorders research4%
  • Aortic Disease and Treatment Approaches3%
  • その他69.2%

共著者

全論文

検索で開く
  1. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 2,709

  2. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 461

  3. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roddy Walsh, Jessica Wang, James S. Ware, Ray E. Hershberger - Circulation 2021 被引用: 512

  4. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2019 被引用: 806

  5. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2020 被引用: 285

  6. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 被引用: 534

  7. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework

    著者: , , , , , , , , , , , , , , , , , , , - Circulation Genomic and Precision Medicine 2021 被引用: 234

  8. Epidemiology of the inherited cardiomyopathies

    著者: , - Nature Reviews Cardiology 2020 被引用: 252

  9. Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The IMAC-2 and IPAC Investigators, Zolt Arany - Circulation 2021 被引用: 179

  10. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

    著者: , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2011 被引用: 1,468

  11. Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers

    著者: , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 695

  12. Arrhythmogenic Cardiomyopathy

    著者: , , - Circulation Research 2017 被引用: 442

  13. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

    著者: , , , , , , , , , , , , , , , , , , , - Science 2006 被引用: 1,797

  14. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2005 被引用: 1,778

  15. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 255

  16. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy

    著者: , , , , , , , , , , - Circulation 2019 被引用: 190

  17. Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial ( ATTR‐ACT ) and long‐term extension study

    著者: , , , , , , , , , , - European Journal of Heart Failure 2020 被引用: 208

  18. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Genetics 2015 被引用: 481

  19. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sanjay Sharma, Hari Tandri, Anneline S.J.M. te Riele, Gaetano Thiene, Adalena Tsatsopoulou, Wojciech Zaręba, Alessandro Zorzi, Thomas Wichter, Gregory M. Marcus, Hugh Calkins, International Experts, Aris Anastastakis, Angeliki Asimaki, Cristina Basso, Barbara Bauce, Corinna Brunckhorst, Chiara Bucciarelli‐Ducci, Hugh Calkins, Domenico Corrado, Firat Duru, Perry Elliott, Robert M. Hamilton, Richard N.W. Hauer, Kristina H. Haugaa, Cynthia A. James, Daniel P. Judge, Mark S Link, Francis E Marchlinski, Gregory M. Marcus, William J. McKenna, Andrea Mazzanti, Luisa Mestroni, Antonis Pantazis, Antonio Pelliccia, Martina Perazzolo Marra, Kalliopi Pilichou, Pyotr G A Platonov, Alexandros Protonotarios, Alessandra Rampazzo, Jeffry E Saffitz, Ardan M. Saguner, Christian Schmied, Sanjay Sharma, Hari Tandri, Anneline S.J.M. te Riele, Gaetano Thiene, Adalena Tsatsopoulou, Peter J van Tintelen, Thomas Wichter, Wojciech Zaręba, Alessandro Zorzi - European Heart Journal 2019 被引用: 362

  20. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

    著者: , , , , , , , , , - Genetics in Medicine 2018 被引用: 283

  21. Phospholamban R14del Mutation in Patients Diagnosed with Dilated Cardiomyopathy or Arrhythmogenic Right Ventricular Cardiomyopathy: Evidence Supporting the Concept of Arrhythmogenic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2012 被引用: 458

  22. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jiangping Song, Daniel P. Judge, William J. McKenna, Matthew R.G. Taylor, Gianfranco Sinagra, Luisa Mestroni - Circulation 2021 被引用: 103

  23. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

    著者: , , , , , , , , , , , , , , , - Cardiovascular Drugs and Therapy 2020 被引用: 106

  24. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Guertin, J. Peter van Tintelen, Pyotr G. Platonov, Fırat Duru, Kristina H. Haugaa, Paul Khairy, Richard N.W. Hauer, Hugh Calkins, Anneline S.J.M. te Riele, Cynthia A. James - European Heart Journal 2022 被引用: 128